Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MAGNA CoQ10
- Development stage
- Unknown
- Lead developer
- Magna Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
MAGNA CoQ10 is an oral dietary supplement developed and marketed by Magna Pharmaceuticals (Magna Invests). Each softgel contains 200 mg of Coenzyme Q10 (ubiquinone), an essential fat-soluble coenzyme synthesized naturally in the body. The product is formulated in a fatty acid suspension of safflower oil to enhance absorption, allowing for administration without food. Coenzyme Q10 serves as a critical cofactor in the mitochondrial electron transport chain, facilitating the production of adenosine triphosphate (ATP) during cellular respiration. Additionally, it acts as a potent lipid-soluble antioxidant, protecting cell membranes and lipoproteins from oxidative damage. MAGNA CoQ10 is indicated for cardiovascular support, mitochondrial energy production, and general wellness, particularly for individuals seeking to maintain healthy cholesterol levels.
- Brand names
- MAGNA CoQ10
- Other names
- Coenzyme Q10CoQ10CoQ-10CoQ 10ubiquinone
02
Targets
ND1 (Mitochondrial electron transport chain complex I)
Beyond the preview
Go deeper on MAGNA CoQ10.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MAGNA CoQ10.